However, for Reg he wanted to be part of something bigger. Following a cancer diagnosis 13 years ago, Reg volunteered to participate in five consecutive medical trials taking place at .

Staff of the Medical Oncology Clinical Trials Unit, together with our Director of Medical Oncology, Director of Mission Integration and Public Affairs and Communications Manager, recently came together with members of his family, to recognise and celebrate Reginald’s tireless dedication and contribution to research following his death in June 2024.

Reg’s wife, Pam, together with his sister, sons, granddaughter, and close family friends, were welcomed into the hospital for afternoon tea, to share memories of this remarkable man and for his dedication to medical research to be acknowledged.

“The Mater has been such a large part of our lives over the past few years. At times we have felt like we have lived here,” Pam said.

“From day one of the first trial we felt involved, informed and part of the team. It was a special feeling, especially at a time of uncertainty in our lives,” she commented.

For Pam and Reg, his participation in the trial shed a new light on trials. Throughout the years they grew a new understanding of the process and always felt able to ask questions. Pam said, “The Medical Oncology Clinical Trials ladies who looked after us have been wonderful, they have been integral to our participation throughout the years. As have the doctors including Dr Craig Gedye who Reg had such a wonderful rapport with.”

His son, Ben, explained that from the very outset Reg was keen to try and help himself, as he was fighting for his life, however, he had such a drive to help others through participating in the research.

“Some of the trials had unpleasant side effects but he bore it really well. He was just proud to be part of something bigger. Even when we knew the inevitable outcome of the spread of his cancer, Reg made his participation in the trials part of his legacy. He continued participating until two months before his passing,” Pam said.

Over the years the Mater’s Medical Oncology Clinical Trial Unit has been involved in pivotal work that has resulted in new treatment options for people with a range of cancers, from breast and bowel cancer to supportive care of patients receiving chemotherapy. Reg’s incredible contribution was recognised by the team and by the hospital as a whole.

Ben concludes, “We hope that one day a cure or new treatment options will be found and as a family we will know Dad was part of it.”